FDA: Trace amounts of carcinogen prompts blood pressure medication recall

Recalls

Nashville 2019

More Nashville 2019

Thousands of bottles of blood-pressure medicine are being recalled after the Food and Drug Administration said trace amounts of potential carcinogens were found to be in the medicine.

Camber Pharmaceuticals is pulling about 56,000 bottles of Losartan, which is used to treat high blood pressure and congestive heart failure.

The recall affects 25 mg, 50 mg, and 100 mg tablets.

According to the FDA, no one has reported any adverse effects from the drug.

Patients should speak with their doctor to discuss the recall before they stop taking the drug.

The identifying NDC #s associated with Camber’s product as are follows: Losartan 25 mg 31722-700-90, 31722-700-05, 31722-700-10; Losartan 50 mg 31722-701-30, 31722-701-90, 31722-70-10; and Losartan 100 mg 31722-702-30, 31722-702-90, and 31722-702-10.

Consumers with questions regarding this recall can contact Camber Pharmaceuticals’ Med Line at 1-866-495-1995 Monday – Friday, 9 a.m. – 5 p.m. EST. 

Click here for more information on the Losartan recall.

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

Don't Miss

Community Calendar